Contents
pdf Download PDF pdf Download XML
102 Views
22 Downloads
Share this article
Research Article | Volume 5 Issue 3 (None, 2011) | Pages 50 - 52
Progressive symmetrical erythrokeratoderma - response to topical calcipotriol
 ,
 ,
 ,
Under a Creative Commons license
Open Access
PMID : PMC3184781
Received
May 17, 2011
Published
Sept. 21, 2011
Abstract

Background:Progressive symmetrical erythrokeratoderma is characterized by well-demarcated, symmetrically distributed, erythtematous and hyperkeratotic plaques. Treatment options are topical retinoids, emollients, keratolytics and topical corticosteroids with limited or no success. Oral retinoids have been shown to be successful in some cases, but recurrence is to be expected on cessation of therapy. Topical calcipotriol is an established mode of treatment for psoriasis and also reported to be effective in many hyperkeratotic skin diseases.Main observations:A 20-year-old female patient presented with reddish-brown lesions in her axillae, groins, submammary regions and on the eyelids. Clinical and histological findings were consistent with the diagnosis of progressive symmetrical erythrokeratoderma. She had noted that her lesions did not improve with topically applied steroids and emollients. We recommended our patient to use topical calcipotriol and observed a remarkable improvement withintwoweeks.Conclusion:When compared with the other treatment modalities, topical calcipotriol is a safe and effective drug with minimal side effects and it would be a good alternative.

Keywords
Recommended Articles
Research Article
Impact of COVID-19 on Sexually Transmitted Infection Burden: A Cross-Sectional Study from a Tertiary Care Hospital in Gujarat
...
Published: 02/08/2025
Original Article
An analysis of Morphometric characteristics of Supratrochlear foramen of humerus
Published: 08/06/2025
Original Article
Outcomes of Plastic Surgical Reconstruction of Diabetic Foot Ulcers Following Systemic Optimization and Local Infection Control: A Prospective Study
...
Published: 08/06/2025
Research Article
Comparative Study of Oral Levamisole versus Oral Betamethasone in Vitiligo: A Prospective Analysis.
...
Published: 28/06/2025
© Copyright Spejalisci Dermatolodzy